Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Relation between invasive hemodynamics and measured glomerular filtration rate by 51Cr-EDTA clearance in advanced heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Validation of plasma thyroxine and triiodothyronine methods on the ADVIA Centaur® XP

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Phenylephrine increases near-infrared spectroscopy determined muscle oxygenation during head-up tilt in men

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pediatric reference intervals for general clinical chemistry components - merging of studies from Denmark and Sweden

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Age-related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. In-hospital metabolite changes in infective endocarditis-a longitudinal 1H NMR-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Repeatability and Reproducibility of Neonatal Echocardiography: The Copenhagen Baby Heart Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Congenital myopathies are mainly associated with a mild cardiac phenotype

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Fabry disease is an X- linked inherited lysosomal storage disease caused by mutations in the GLA gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A). The possible pathological significance of the D313Y variant in the GLA gene has not been verified and it may be a Fabry variant. Our aim was to elucidate whether the presence of the D313Y variant influenced the α-Gal A activity or resulted in Fabry symptoms or Fabry organ involvement. In two Danish families the presence of the D313Y variant did not result in reduced α-Gal A activity or clinical Fabry manifestations in males, and the presence in Fabry females did not significantly enhance the phenotype of a known causative mutation in the GLA gene (G271S). Our findings indicate that the D313Y variant is not causative to nor enhancing Fabry disease phenotype. The D313Y variant in the GLA gene was not disease causative in 2 Danish families. Investigating male family members were crucial in excluding the Fabry phenotype, and thus very important for proper genetic counceling of all family members, as well as overdiagnosing a devastating genetic disease.

Original languageEnglish
JournalScandinavian Journal of Clinical and Laboratory Investigation
Volume77
Issue number8
Pages (from-to)617-621
Number of pages5
ISSN0036-5513
DOIs
Publication statusPublished - Dec 2017

    Research areas

  • Journal Article

ID: 52175839